Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.
2.

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)

Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadziyannis S, Degos F, de Moura MC, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW.

Am J Gastroenterol. 1998 Jun;93(6):896-900.

PMID:
9647014
3.

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).

Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, Giustina G, Noventa F.

J Hepatol. 1994 Oct;21(4):656-66.

PMID:
7814813
5.

Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls.

Vo Thi Diem H, Bourgois A, Bontems P, Goyens P, Buts JP, Nackers F, Tonglet R, Sokal EM.

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):141-5.

PMID:
15699686
6.

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.

Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, Krogsgaard K, Degos F, Carneiro de Moura M, et al.

Hepatology. 1995 Jan;21(1):77-82.

PMID:
7806171
7.

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.

Hepatology. 2004 Mar;39(3):804-10.

PMID:
14999700
8.

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.

Truong BX, Seo Y, Kato M, Hamano K, Ninomiya T, Katayama M, Kato H, Yano Y, Hayashi Y, Kasuga M.

Int J Mol Med. 2005 Aug;16(2):279-84.

PMID:
16012762
9.

Long term effect of alpha interferon in children with chronic hepatitis B.

Bortolotti F, Jara P, Barbera C, Gregorio GV, Vegnente A, Zancan L, Hierro L, Crivellaro C, Vergani GM, Iorio R, Pace M, Con P, Gatta A.

Gut. 2000 May;46(5):715-8.

10.

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).

Fattovich G, Giustina G, Degos F, Diodati G, Tremolada F, Nevens F, Almasio P, Solinas A, Brouwer JT, Thomas H, Realdi G, Corrocher R, Schalm SW.

J Hepatol. 1997 Jul;27(1):201-5.

PMID:
9252096
11.

The long-term course of chronic hepatitis B.

Di Marco V, Lo Iacono O, Cammà C, Vaccaro A, Giunta M, Martorana G, Fuschi P, Almasio PL, Craxì A.

Hepatology. 1999 Jul;30(1):257-64.

PMID:
10385664
12.

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.

Am J Gastroenterol. 2005 Nov;100(11):2463-71.

PMID:
16279901
13.

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.

J Med Virol. 2007 Sep;79(9):1286-92.

PMID:
17607775
14.

Determinants of outcome of compensated hepatitis C virus-related cirrhosis.

Serfaty L, Aumaître H, Chazouillères O, Bonnand AM, Rosmorduc O, Poupon RE, Poupon R.

Hepatology. 1998 May;27(5):1435-40.

PMID:
9581703
15.

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.

de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M.

Gastroenterology. 1992 Nov;103(5):1630-5.

PMID:
1426884
16.

Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.

Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1250-8. doi: 10.1111/j.1440-1746.2008.05499.x. Epub 2008 Jul 8.

PMID:
18624896
18.

A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.

Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.

Liver Int. 2008 Aug;28(7):1034-41. doi: 10.1111/j.1478-3231.2008.01766.x. Epub 2008 May 19.

PMID:
18492018
19.

[Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].

Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.

Zhonghua Yi Xue Za Zhi. 2007 Jul 10;87(26):1840-3. Chinese.

PMID:
17922996
20.

Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.

Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY.

J Hepatol. 2007 Nov;47(5):684-90. Epub 2007 Aug 13.

PMID:
17854945

Supplemental Content

Support Center